MARKET

CFX

CFX

Colfax
NYSE

Real-time Quotes | Nasdaq Last Sale

45.17
+0.76
+1.70%
Opening 14:39 09/22 EDT
OPEN
44.75
PREV CLOSE
44.41
HIGH
45.33
LOW
44.66
VOLUME
624.85K
TURNOVER
--
52 WEEK HIGH
50.34
52 WEEK LOW
26.45
MARKET CAP
6.43B
P/E (TTM)
61.83
1D
5D
1M
3M
1Y
5Y
DJO(R) Expands Active, Adaptive Healing Offerings with Introduction of MedShape(R) DynaNail Hybrid(TM)
DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced the launch of the MedShape(R) DynaNail Hybrid(TM) Fusion System. The latest addition to DJO's robust su...
Business Wire · 7h ago
DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™
DALLAS, September 22, 2021--DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™
Business Wire · 7h ago
Colfax Unit DJO Rolls Out MedShape DynaNail Hybrid
MT Newswires · 9h ago
Colfax Corp (CFX) President & CEO Matthew L. Trerotola Sold $2.8 million of Shares
GuruFocus News · 6d ago
Insider Sell: Colfax
MT Newswires · 6d ago
Colfax (CFX) to Gain From Demand & Buyouts Amid Cost Woes
Zacks.com · 09/10 12:57
Goldman Sachs Downgrades Colfax to Neutral, Lowers Price Target to $51
Goldman Sachs analyst Joe Ritchie downgrades Colfax (NYSE:CFX) from Buy to Neutral and lowers the price target from $53 to $51.
Benzinga · 09/10 09:29
Goldman Sachs Downgrades Colfax to Neutral from Buy, Adjusts Price Target to $51 from $53
MT Newswires · 09/10 08:56
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CFX. Analyze the recent business situations of Colfax through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CFX stock price target is 53.57 with a high estimate of 63.00 and a low estimate of 44.00.
EPS
Institutional Holdings
Institutions: 396
Institutional Holdings: 148.03M
% Owned: 103.99%
Shares Outstanding: 142.34M
TypeInstitutionsShares
Increased
109
10.99M
New
18
5.93M
Decreased
101
11.19M
Sold Out
56
3.08M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Industrial Machinery & Equipment
+1.68%
Machinery, Tools, Heavy Vehicles, Trains & Ships
+1.87%
Key Executives
Chairman/Director
Mitchell Rales
President/Chief Executive Officer/Director
Matthew Trerotola
Chief Financial Officer/Executive Vice President - Finance
Christopher Hix
Corporate Executive
Brady Shirley
Chief Human Resource Officer/Senior Vice President
Patricia Lang
Executive Vice President
Shyam Kambeyanda
Executive Vice President
Daniel Pryor
Senior Vice President/General Counsel/Secretary
Bradley Tandy
Lead Director/Independent Director
Patrick Allender
Independent Director
Thomas Gayner
Independent Director
Rhonda Jordan
Independent Director
Liam Kelly
Independent Director
Philip Okala
Independent Director
A. Clayton Perfall
Independent Director
Didier Teirlinck
Independent Director
Rajiv Vinnakota
Independent Director
Sharon Wienbar
No Data
About CFX
Colfax Corporation is a technology company. The Company provides orthopedic care and fabrication technology products and services. It operates through two segments: Fabrication Technology and Medical Technology. Fabrication Technology segment is a supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. Medical Technology segment is a provider of orthopedic solutions, providing orthopedic devices, software and services. Its fabrication technology products are marketed under the ESAB brand. ESAB's range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. The Company, through its subsidiary DJO Global, Inc. (DJO), provides medical devices that provide solutions for musculoskeletal health, vascular health and pain management. It also provides devices for fracture fixation, joint fusion and soft tissue injury repair. Its brands include Aircast, Chattanooga, Regeneration, COMPEX, DJO Surgical and PROCARE.

Webull offers kinds of Colfax Corp stock information, including NYSE:CFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CFX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CFX stock methods without spending real money on the virtual paper trading platform.